iTeos Therapeutics Inc. (ITOS)
NASDAQ: ITOS
· Real-Time Price · USD
9.95
-0.01 (-0.10%)
At close: Jun 23, 2025, 12:19 PM
-0.10% (1D)
| Bid | 9.94 |
| Market Cap | 380.63M |
| Revenue (ttm) | 35M |
| Net Income (ttm) | -130.81M |
| EPS (ttm) | -3.05 |
| PE Ratio (ttm) | -3.26 |
| Forward PE | -6.37 |
| Analyst | Hold |
| Ask | 9.97 |
| Volume | 320,057 |
| Avg. Volume (20D) | 1,289,474 |
| Open | 9.99 |
| Previous Close | 9.96 |
| Day's Range | 9.95 - 10.03 |
| 52-Week Range | 4.80 - 18.13 |
| Beta | 1.51 |
About ITOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ITOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ITOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+17.94%
ITeos Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+13.44%
ITeos Therapeutics shares are trading higher after the company reported topline interim results from its GALAXIES Lung-201 study of Belrestotug + Dostarlimab.
